Review Special Issues

Exploring ginseng's potential role as an adjuvant therapy in COVID-19

  • Received: 31 October 2023 Revised: 01 December 2023 Accepted: 07 December 2023 Published: 18 December 2023
  • Ginseng is a plant from the Panax genus used since ancient times as a prominent component of traditional Chinese medicine, and is prized for its energizing, antiaging and antioxidant properties. Over time, the scientific community has taken a keen interest in ginseng's potential as a supplement in various health sectors. While there is a substantial body of data demonstrating the effectiveness of ginseng and other natural products as adjuncts in the treatment of respiratory diseases, the emergence of the COVID-19 pandemic has amplified the attention on ginseng and its extracts as potential antiviral and antibacterial agents. This review aims to summarize the potential benefits of ginseng in the prevention of COVID-19, the alleviation of symptoms and the enhancement of clinical outcomes for patients. It suggests incorporating ginseng and other natural compounds into complementary therapeutic regimens to augment the effectiveness of vaccines and pharmacological treatments. However, it's important to note that further experiments and clinical studies are necessary to solidify the efficacy of ginseng against COVID-19 and to establish its use as a viable option.

    Citation: Lisa Aielli, Chman Shahzadi, Erica Costantini. Exploring ginseng's potential role as an adjuvant therapy in COVID-19[J]. AIMS Allergy and Immunology, 2023, 7(4): 251-272. doi: 10.3934/Allergy.2023017

    Related Papers:

    [1] Shadrack Mubanga Chisenga, Tilahun Seyoum Workneh, Geremew Bultosa, Mark Laing . Characterization of physicochemical properties of starches from improved cassava varieties grown in Zambia. AIMS Agriculture and Food, 2019, 4(4): 939-966. doi: 10.3934/agrfood.2019.4.939
    [2] Rajesh Chakraborty, Tuhin Suvra Roy, Jun-Ichi Sakagami . Grain yield, cooking quality, and aroma of fragrant rice as affected by nitrogen source and method of application. AIMS Agriculture and Food, 2024, 9(4): 1027-1048. doi: 10.3934/agrfood.2024055
    [3] Wira Hadianto, Bambang Sapta Purwoko, Iswari Saraswati Dewi, Willy Bayuardi Suwarno, Purnama Hidayat, Iskandar Lubis . Agronomic performance, yield stability and selection of doubled haploid rice lines in advanced yield trials. AIMS Agriculture and Food, 2023, 8(4): 1010-1027. doi: 10.3934/agrfood.2023054
    [4] Eric Tzyy Jiann Chong, Lucky Poh Wah Goh, Mariam Abd. Latip, Zaleha Abdul Aziz, Noumie Surugau, Ping-Chin Lee . Genetic diversity of upland traditional rice varieties in Malaysian Borneo based on mitochondrial cytochrome c oxidase 3 gene analysis. AIMS Agriculture and Food, 2021, 6(1): 235-246. doi: 10.3934/agrfood.2021015
    [5] Nurafi Razna Suhaima, Nugraha Edhi Suyatma, Dase Hunaefi, Anuraga Jayanegara . Comparison of fish and mammalian gelatin film properties: A meta-analysis. AIMS Agriculture and Food, 2022, 7(3): 461-480. doi: 10.3934/agrfood.2022029
    [6] Ilaria Marotti, Giovanni Dinelli, Valeria Bregola, Sara Bosi . Nutritional characterization of Italian common bean landraces (Phaseolus vulgaris L.): fatty acid profiles for “genotype-niche diversity” fingerprints. AIMS Agriculture and Food, 2020, 5(4): 543-562. doi: 10.3934/agrfood.2020.4.543
    [7] Budi Suarti, Sukarno, Ardiansyah, Slamet Budijanto . Bio-active compounds, their antioxidant activities, and the physicochemical and pasting properties of both pigmented and non-pigmented fermented de-husked rice flour. AIMS Agriculture and Food, 2021, 6(1): 49-64. doi: 10.3934/agrfood.2021004
    [8] Christos Dramalis, Demetrios Katsantonis, Spyridon D. Koutroubas . Rice growth, assimilate translocation, and grain quality in response to salinity under Mediterranean conditions. AIMS Agriculture and Food, 2021, 6(1): 255-272. doi: 10.3934/agrfood.2021017
    [9] Marcelo Augusto de Carvalho, Cíntia Sorane Good Kitzberger, Altamara Viviane de Souza Sartori, Marta de Toledo Benassi, Maria Brígida dos Santos Scholz, Clandio Medeiros da Silva . Free choice profiling sensory analysis and principal component analysis as tools to support an apple breeding program. AIMS Agriculture and Food, 2020, 5(4): 769-784. doi: 10.3934/agrfood.2020.4.769
    [10] Admasu F. Worku, Karta K. Kalsa, Merkuz Abera, Habtu G. Nigus . Effects of storage strategies on physicochemical properties of stored wheat in Ethiopia. AIMS Agriculture and Food, 2019, 4(3): 578-591. doi: 10.3934/agrfood.2019.3.578
  • Ginseng is a plant from the Panax genus used since ancient times as a prominent component of traditional Chinese medicine, and is prized for its energizing, antiaging and antioxidant properties. Over time, the scientific community has taken a keen interest in ginseng's potential as a supplement in various health sectors. While there is a substantial body of data demonstrating the effectiveness of ginseng and other natural products as adjuncts in the treatment of respiratory diseases, the emergence of the COVID-19 pandemic has amplified the attention on ginseng and its extracts as potential antiviral and antibacterial agents. This review aims to summarize the potential benefits of ginseng in the prevention of COVID-19, the alleviation of symptoms and the enhancement of clinical outcomes for patients. It suggests incorporating ginseng and other natural compounds into complementary therapeutic regimens to augment the effectiveness of vaccines and pharmacological treatments. However, it's important to note that further experiments and clinical studies are necessary to solidify the efficacy of ginseng against COVID-19 and to establish its use as a viable option.



    Combustion of crude oil-derived fossil fuels that contain sulfur compounds leads to the release of sulfur oxides into the atmosphere, increasing air pollution and contributing to the deterioration of environmental quality [1]. Environmental protection agencies worldwide have imposed strict regulations on combustible fossil fuel products. The current desulfurization technology of oil products involves the catalytic reduction of organic sulfur to H2S at elevated temperatures using hydrogen through the process of hydrodesulfurization (HDS). While the process works well for thiols and sulfides, it becomes energy-intensive when it reaches the temperatures required to remove heterocyclic sulfur compounds (thiophene derivatives). This step is necessary for achieving the high desulfurization levels imposed by regulations [2]. In addition to the elevated cost, these temperatures also result in quality deterioration of the final product. As a result, alternative technologies are being explored, mainly targeting petroleum products' recalcitrant heterocyclic sulfur compounds [2],[3]. Among them, the most promising is the biodesulfurization (BDS) process. This term denotes the microbially mediated removal of benzothiophene (BT), dibenzothiophene (DBT), and their alkylated homologs from various oil products when in contact with microbial biomass (biphasic systems). The process has been reported to be associated with diverse microbial genera and can be potentially used for industrial-scale desulfurization [4].

    In literature, most BDS studies have focused on DBT as the model heterocyclic sulfur compound. This fact has resulted in the explication of two major biochemical utilization pathways, the ring destructive (degradation) or “Kodama pathway” and the sulfur-specific (desulfurization) "4S" sulfur removal pathway. The Kodama pathway is often characterized as a "destructive" BDS pathway, in which carbon-carbon bonds in the DBT molecules are broken, leading to the loss of only one phenolic ring with the S molecule remaining in an organic form. As a result, the majority of research has been focused on the 4S pathway (Figure 1), as it is an oxidative desulfurization pathway that cleaves the carbon-sulfur bond in DBT, yielding 2-hyrdoxybiphenyl (2-HBP) and sulfite ions as final products, thus not affecting the carbon content of the processed fuel [5]. Few researchers have further demonstrated the existence of an extended 4S pathway in some bacterial species such as Achromobacter and Mycobacterium spp, where the 2-HBP formed from DBT is partially converted to 2-methoxybiphenyl (2-MBP), although the exact mechanism and enzymes involved in this conversion remain uncharacterized [6][8]. The first characterized desulfurization pathway is from Rhodococcus qingshengii strain IGTS8 [9], formerly identified as R. erythropolis [10]. It involves the enzymes that catalyze the cleavage of carbon-sulfur bond and the well-characterized genes that encode them. The desulfurization operon designated as dszABC lies in a 150 kb plasmid and includes three genes that encode enzymes for the progressive conversion of DBT to 2-HBP. The reductive power required is supplied through the action of an NADH-FMN oxidoreductase, namely DszD, encoded in the genomic DNA. The conversion process comprises of three steps. During the first two steps, DBT is converted to dibenzothiophene sulfoxide (DBTO) and subsequently to dibenzothiophene sulfone (DBTO2). The third step involves the conversion of DBTO2 to 2-hydroxybiphenyl-2-sulfinate (HBPS) and ultimately to 2-HBP (Figure 1) [2]. This dsz genotype appears to be well preserved among a significant number of diverse genera that share homologs of Dsz enzymes [11],[12].

    Over the last twenty years, a significant amount of research work has been conducted on various aspects of the BDS process, including the quest for new and more efficient wild-type biodesulfurizing strains, the optimization of their culture conditions and performance in various BDS-reactor configurations, the homologous or heterologous overexpression of the Dsz enzymes into miscellaneous hosts etc. [13][15]. Despite this, BDS is still far from any economically viable industrial application. Several reasons have been stated for this situation, with the most prominent being the low overall biodesulfurizing activity of the microbial biocatalysts, that is usually accompanied by their low viability and stability, especially when in contact with petroleum products [16].

    Figure 1.  The 4S pathway for the biocatalytic desulfurization of DBT and its derivatives. Final editing was concluded with the tools provided by BioRender.com.

    Targeting towards the latter two important impediments for enhanced BDS in this work, the bioprospecting for new microbial isolates with enhanced BDS phenotypes was pursued. For strain isolation a unique Greek environment was selected, namely the Keri marsh in the island of Zakynthos, Western Greece, an area characterized by slow and continuous crude oil escapes from the ground. Considering the complexity of heterocyclic sulfur sources that are present in petroleum products, and the increased recalcitrancy of the alkylated forms of DBT that are the primary S-compounds in diesel [17],[18], an enrichment process of the soil samples based on 4,6 dimethyl dibenzothiophene (4,6-DM-DBT) was performed aiming to identify more robust BDS biocatalysts [19],[20]. Following the isolation of new biodesulfurization strains and the evaluation of their performance as BDS biocatalysts, we additionally developed an elaborate stability-viability assay in an effort to examine the stability and viability kinetics of both cells and related BDS activity in biphasic systems using model and real-life diesel samples.

    The sampling area (supplementary data, Figure S1) is Keri Lake's ancient so-called 'Herodotus Springs'. It is a coastal ecosystem in the southern part of Zakynthos Island, in the Ionian Sea. Its area is approximately 30,000 m2 with an average elevation of 1 m above sea level [21]. Keri Lake is separated from the open sea by a low sand barrier, limiting communication with the open sea. The initial limnic environment evolved into a coastal fen covered mainly with reeds, which led to the accumulation of a 5 m thick peat bed below the fen environment [21]. The oil escape at Keri Lake has been a well-known physical phenomenon for 2500 years (Herodotus, Book IV, Chapter 195). Former geochemical analyses of the escaping oil have revealed a marine organic matter origin with a high maturity level and abundance of aromatic compounds [22]. Five crude-oil contaminated sediment samples were collected randomly from the sampling area. Sediment samples (10 cm deep) were taken under aseptic conditions, using sterile equipment. The samples were transferred into 50 mL polypropylene Falcon tubes using sterilized spatulas, preventing air exposure as much as possible. The tubes were stored at 4–6 °C and transferred to the lab within 24 hours where they were kept at the same temperature (for a maximum of one week) until further processing.

    The sulfur-free chemically defined medium (CDM) was used throughout this work. It was comprised of (in g/L): NaH2PO4·H2O, 3.8; Na2HPO4·7H2O, 3.3; NH4Cl, 0.8; NaCl, 8.5; KCl, 0.5. The following components were added to the autoclaved medium, from filter-sterile stock solutions: Solution C: (1 mL/L)-MgCl2·6H2O (324 g/L) and CaCl2·2H2O (29.4 g/L), Solution D: (10 mL/L)-containing (per L) Na2SeO3·5H2O, 6 mg; Na2WO4·2H2O, 8 mg; and NaOH, 0.4 g. Trace element stock solution: (1 mL/L)–Na2·EDTA (5.2 g/L); FeCl2·4H2O (3 mg/L); H3BO3 (30 mg/L); MnCl2·4H2O (100 mg/L); CoCl2·6H2O (190 mg/L); NiCl2·6H2O (24 mg/L); CuCl2 (0.2 mg/L); ZnCl2 (0.5 mg/L); and Na2MoO4·2H2O (36 mg/L). Vitamin stock solution (1 mL/L), containing (per L): D (+) biotin, 10 mg; 4-aminobenzoic acid, 40 mg; nicotinic acid, 100 mg; calcium D-(+)-pantothenate, 50 mg; pyridoxamine-dihydrochloride, 25 mg; thiamin dihydrochloride/L, 50 mg; vitamin B12, 50 mg. This medium was supplemented, depending on the experiment, with different carbon (glucose, glycerol, ethanol) and sulfur (dimethyl sulfoxide-DMSO, dimethyl sulfone-DMSO2, taurine, DBT, 4,6-DM-DBT, sodium sulphate) sources at the indicated concentrations. In the experiment for the nitrogen source effect, NH4Cl was replaced with other nitrogen sources (NH4NO3, NaNO3, urea). When used, DBT was added from 100 mM ethanol stock while 4,6-DM-DBT was similarly prepared in acetone. All media were prepared in high purity (HPLC grade) water (PanReac, Applichem). A slight adjustment with 1M NaOH was performed, when necessary, in order to reach an initial value of pH 7.

    Enrichment cultures under aerobic conditions were performed in CDM with 0.5 mM 4,6-DM-DBT as sulfur source and 110 mM glycerol as carbon source and incubated at 30 °C under shaking (180 rpm). Erlenmeyer flasks (100 mL) were filled with 20 mL medium and inoculated with 2 grams (wet weight) of the sediment sample. The incubation lasted for seven days when 2 mL of the respective enrichment culture was transferred into 18 mL fresh medium which was further incubated for additional seven days. Following five enrichment cycles, whole culture broth from the enrichment cultures were serially diluted in sterile PBS. 0.1 mL from the 10−2, 10−4, and 10−6 serial dilutions were spread on the same enrichment medium agar plates. The plates were prepared in duplicate and incubated at 30 °C. The CDM plates were incubated for 72 h, and the developed colonies were purified by repeated streaking on the same medium till pure colonies were obtained.

    Bacterial isolation and purification of genomic DNA were performed using the NucleoSpin Microbial DNA purification kit (Macherey-Nagel), according to the manufacturer's recommendation. DNA quantification was determined using Thermo Scientific NanoDropTM 2000c Spectrophotometer. Strain identification was based on the amplification of the 16S rRNA gene using the universal primers 27F and 1492R, which span nearly the entire length of the gene with an expected amplicon of ~1400bp (supplementary data, Table S1). The PCR products were directly sequenced using a BigDye terminator cycle sequencing. The nucleotide sequences were then submitted to GenBank (accession numbers ON678184 to ON678199 and ON680692).

    To confirm the existence of desulfurization (dsz) genes in the isolates' genomes, primers based on known sequences from R. qingshengii IGTS8 (GenBank accession numbers U08850.1 for dszABC, CP029297.1 for dszD) were used (supplementary data, Table S1). All PCR amplifications were performed using Taq DNA polymerase (MBI Fermentas, Lab Supplies, Athens, Greece), according to the manufacturer's instructions. DNA and amino acid sequences were analyzed using the BLAST programs of the National Center for Biotechnology Information.

    The evolutionary history was determined through the Maximum Likelihood (ML) method and Tamura-Nei model [23]. The tree with the highest log likelihood (-38750.95) is shown. Initial tree for the heuristic search was obtained automatically by applying Neighbor-Join (NJ) and BioNJ [24] algorithms to a matrix of pairwise distances estimated using the Tamura-Nei model, and then selecting the topology with superior log likelihood value. The final dataset comprised of 54 partial 16S ribosomal RNA (16S rRNA) gene sequences retrieved from GenBank. The phylogenetic tree was constructed using partial 16S rRNA gene sequences. Alignment and nucleotide content was calculated using the general-purpose nucleotide search and alignment program BLASTn. Furthermore, MUSCLE was used for aligning the nucleotide sequences. Evolutionary analyses were conducted in MEGA11 [25]. The Newick notation was then transferred to the online tool iTOL (Interactive Tree Of Life) [26] for further annotation and data implementation.

    To examine the effect of different media on growth and desulfurization activity, the wild-type strain R. qingshengii IGTS8 and the isolated strains R. qingshengii ATHUBA4003 and ATHUBA4006 were grown in CDM pH = 7.0, under different carbon, nitrogen, and sulfur sources of a predefined concentration. Growth took place in 96-well cell culture plates (F-bottom; Greiner Bio-One, Fischer Scientific, US) in thermostated plate shakers at 30 °C and 600 rpm as previously described [27]. An initial biomass concentration of 0.045–0.055 g/L (dry cell weight) was universally applied, while 60 identical well-cultures were used per condition (150 µL culture per cell). Biomass concentration, expressed as Dry Cell Weight (DCW), was estimated by measuring the optical density at 600 nm with a Multiskan GO Microplate Spectrophotometer (Thermo Fisher Scientific, Waltham, MA USA), using an appropriate calibration curve.

    Desulfurization activity was determined through a resting cells assay [28]. In brief, the content of 4 to 8 wells from each condition (depending on the growth stage) was removed, mixed in a 1.5 mL Eppendorf tube, centrifuged for 5 min at 1000xg, and cell pellets were resuspended in 50 mM Hepes buffer (pH = 8.0) to a final concentration between 0.5 and 2 g DCW/L. One hundred and fifty µL of cells' suspension were added to 150 µL of 2 mM DBT in the same buffer, in an Eppendorf tube. The tube was incubated in a thermoshaker at 1200 rpm and 30 °C for 30 min. Then, 300 µL acetonitrile was added under stirring, and the tubes were centrifuged to remove the cells. A tube with equivalent amounts of cells and acetonitrile without incubation (t = 0) was used as blank. The supernatant was assayed for 2-HBP determination by HPLC with fluorescence detection [27]. BDS activity was expressed as Units per mg DCW, with 1 U corresponding to the release of 1 nmole 2-HBP per h under the above-described conditions. Final biomass concentration in the collected cells' suspension between 0.5 and 2 g DCW/L did not affect resting cell BDS results (Units/mg DCW) for R. qingshengii IGTS8, ATHUBA4003 or ATHUBA 4006, based on One-way ANOVA with Tukey's multiple-comparison test (confidence interval 95%; n = 2).

    Biphasic model systems were prepared at three different volumetric organic-to-aqueous (OA) ratios, 40/60, 60/40, and 80/20, at a total volume of 1.2 mL in 2 mL Eppendorf tubes. In all experiments, the organic phase comprised partially desulfurized (through HDS) diesel fuel with nominal total sulfur content equal to 100 ppm (obtained from Motor-Oil S.A. refinery at Agioi Theodoroi, Korinthos, Greece). For the aqueous phases, R. qingshengii IGTS8, ATHUBA4003, and ATHUBA4006 strains were grown in CDM with 165 mM ethanol, 1.3 mM DMSO, and 15 mM NH4Cl, as carbon, sulfur, and nitrogen sources, respectively. Growth took place in 250 mL conical flasks (50 mL working volume, 200 rpm) and was closely followed by OD600 measurements up to a cell concentration of 0.5 ± 0.05 mg DCW/mL (approx. mid-exponential phase for all strains). For biphasic BDS system preparation two types of aqueous phases were prepared: In the first, the culture broth was centrifuged, the supernatant discarded, and the cells were washed two times with Ringer solution and resuspended into 50 mM HEPES buffer pH = 8 at a final biomass concentration of 0.5 ± 0.05 mg DCW/mL. Whole culture broth of the same biomass concentration was used directly as the second type of aqueous phase examined. Six biphasic tubes were prepared per condition as described above (12 conditions in total) and were placed in an orbital shaker operating at 1200 rpm and 30 °C. After 4 and 24 hours, three identical tubes were removed from each condition, the upper-organic phase was carefully aspirated, and the lower aqueous phase was used for the determination of the remaining BDS activity (as described above) of the cells, as well as the viable-cell counts, through serial dilutions and spreading on Nutrient-Agar plates.

    The performed enrichment procedure resulted in a microbial consortium that grew in a chemically defined medium containing glycerol and 4,6-DM-DBT as sole carbon and sulfur source, respectively (see Materials and methods). Serial dilutions of the final enrichment subculture plated on the same solid culture medium (on glycerol and 4,6-DM-DBT) revealed several morphologically distinct colonies indicating a mixed culture. A total of 16 distinct strains were isolated and assigned in seven different genera according to their 16S rRNA sequences (Table 1). Furthermore, in order to highlight the phylogenetic position of the isolated strains relative to Rhodococcus qingshengii IGTS8 and other desulfurizing strains from the literature, a phylogenetic tree (Figure 2) was constructed using partial 16S ribosomal RNA (16S rRNA) sequences. The final dataset comprised 54 partial 16S rRNA gene sequences retrieved from GenBank.

    As inferred from Figure 2, the isolated strains cover a wide range of bacterial classes, from actinobacteria to γ-proteobacteria. Among them are included well-studied desulfurizing species belonging to Rhodococcus [3],[29],[30] and Gordonia [31] genera, as well as genera never reported before for the desulfurization of heterocyclic organosulfur compounds like Brucella, Raoultella and Cellulosimicrobium spp. Finally, wild-type strains of the Klebsiella and Pseudomonas genera, that are found in the KL consortium have also been scarcely used in BDS studies [12] or identified as members of desulfurizing microbial communities [32],[33].

    Table 1.  Identification of bacterial strains by 16S rRNA analysis.
    Isolated strains in this work
    16s rRNA identification [% identity to the type strain]
    Strain name GenBank accession no. Type Strains % Identity GenBank accession no.
    Klebsiella grimontii ATHUBA4001 ON678184 Klebsiella grimontii strain SB73 99.78 NR_159317.1
    Klebsiella grimontii ATHUBA4002 ON678185 Klebsiella grimontii strain SB73 99.78 NR_159317.1
    Rhodococcus qingshengii ATHUBA4003 ON678186 Rhodococcus qingshengii strain CCM 4446 100 NR_115708.1
    Klebsiella grimontii ATHUBA4004 ON678187 Klebsiella grimontii strain SB73 99.86 NR_159317.1
    Raoultella terrigena ATHUBA4005 ON678188 Raoultella terrigena strain 84 99.78 NR_037085.1
    Rhodococcus qingshengii ATHUBA4006 ON678189 Rhodococcus qingshengii strain JCM 15477 100 NR_043535.1
    Cellulosimicrobium funkei ATHUBA4007 ON678190 Cellulosimicrobium funkei strain W6122 99.78 NR_042937.1
    Pseudomonas oleovorans ATHUBA4008 ON678191 Pseudomonas oleovorans strain RS1 99.93 NR_115874.1
    Klebsiella pneumoniae ATHUBA4009 ON678192 Klebsiella pneumoniae strain R-70 100 NR_037084.1
    Brucella thiophenivorans ATHUBA4010 ON678193 Brucella thiophenivorans strain DSM 7216 99.38 NR_042599.1
    Pseudomonas aeruginosa ATHUBA4011 ON678194 Pseudomonas aeruginosa strain DSM 50071 100 NR_117678.1
    Pseudomonas aeruginosa ATHUBA4012 ON678195 Pseudomonas aeruginosa strain DSM 50071 100 NR_117678.1
    Brucella rhizosphaerae ATHUBA4013 ON678196 Brucella rhizosphaerae strain PR17 99.54 NR_042600.1
    Brucella anthropi ATHUBA4014 ON678197 Brucella anthropi strain LMG 3331 100 NR_114979.1
    Cellulosimicrobium funkei ATHUBA4015 ON678198 Cellulosimicrobium funkei strain W6122 99.70 NR_042937.1
    Raoultella ornithinolytica ATHUBA4016 ON678199 Raoultella ornithinolytica strain CIP 103364 99.93 NR_044799.1
    Gordonia alkanivorans ATHUBA4017 ON680692 Gordonia alkanivorans strain HKI 0136 99.93 NR_026488.1

     | Show Table
    DownLoad: CSV
    Figure 2.  Maximum Likelihood (ML) phylogenetic tree of the isolates from Keri marsh in Zakynthos island, Greece.

    The fact that all isolated microorganisms originate from an enrichment culture containing 4,6-DM-DBT as a sole sulfur source does not guarantee that they metabolize DBT and its alkylated derivatives without attacking their hydrocarbon skeleton, i.e., through the 4S metabolic pathway (Figure 1). This was true also in the present study, wherein all strains were able to grow on CDM with DBT as the sole carbon source, but significant amounts of 2-HBP–the end-product of the 4S-pathway–were detected only in the R. qingshengii ATHUBA4003 and 4006 cultures (data not shown). The same result was obtained in resting cells assays performed by cells grown on CDM with DMSO as the sulfur source, where 2-HBP was detected as the final product only in the two isolates mentioned above. These results inferred that only the two isolated Rhodococcus strains are metabolizing DBT through the 4S-pathway. The remaining isolates that could grow on and presumably assimilate DBT and 4,6-DM-DBT without producing the corresponding 4S-related end-products most probably utilize a different pathway that does not end up in 2-HBP formation [34],[35]. One known alternative is the Kodama pathway that proceeds by retaining the C-S bond [36] and has been demonstrated to function in Pseudomonads and other proteobacteria [37],[38]. Even for Gordonia spp, a genus with well-known 4S desulfurizing members, additional desulfurizing pathways might exist since, upon growth on benzothiophene, the upregulation of several additional non-4S related genes has been verified [39].

    Following these results, our work was subsequently focused in evaluating the biodesulfurization performance of the two novel R. qingshengii isolates, ATHUBA 4003 and 4006, in reference to the model R. qingshengii IGTS8 strain.

    The resting cells' assay has been extensively used in literature to evaluate the desulfurization potential of bacterial cells as a function of different growth conditions [40]. It consists of adding a certain amount of biomass in a buffered solution of DBT and measuring the amount of 2-HBP produced, following incubation for a certain amount of time, under stirring. Although performed in aqueous conditions, it is the most precise way to estimate the overall Dsz enzymes' activity, at the time point of cell harvesting from the growing culture.

    Carbon source is a substantial cost factor in any biotechnological process and will affect the economic viability of any potentially commercialized BDS process [40],[41]. Thus, we initially examined the effect of carbon source type (glucose, glycerol, and ethanol at 0.33 M carbon) in a low-cost simple salts' medium like CDM, with DMSO as a sole sulfur source (see Section 2). DMSO was selected instead of DBT since it does not have a repressive effect on the dsz-operon [42], in addition to the fact that it is a more convenient sulfur source than DBT for the production of industrial amounts of biocatalyst because of its cost and availability. Finally, at the applied concentration (1.3 mM) it is soluble in water and does not interfere with OD measurements (in contrast to DBT). Figure 3 and related supplementary data Table S2 present the corresponding results.

    Among the carbon sources tested, ethanol proved to be the most efficient in terms of growth and desulfurization efficiency. In this carbon source, strain ATHUBA4006 grew slightly better compared to the other two strains reaching a maximum biomass concentration at the levels of 1.3 g DCW/L. Glycerol supported statistically significant lower growth levels, with ATHUBA4003 isolate showing the highest maximum biomass concentration. Similar maximum BDS activity values were obtained for all strains during the early to mid-log phase (~ 25–30 U/mgDCW). In glycerol, BDS-specific activity was much less affected by the growth phase, with a maximum value not exceeding 20 U/mgDCW for all three strains. It is noteworthy that under the medium matrix employed and the specific experimental conditions, glucose could not establish sufficient growth and any associated BDS activity for any strains.

    Figure 3.  Growth curves (line-symbol plots) and specific desulfurization activities (bar plots) during growth of (A) R. qingshengii IGTS8, (B) R. qingshengii ATHUBA4003, and (C) R. qingshengii ATHUBA4006 in CDM supplemented with different carbon sources (at 330 mM-C). NH4Cl at 15 mM, and DMSO at 1.3 mM was used as nitrogen and sulfur sources, respectively. Data for glycerol and glucose in (Α) are from (Martzoukou et al. 2022). “X” represents biomass concentration (mg dry cell weight /mL).

    Several studies have addressed the selection of carbon source type in relation to BDS activity in rhodococci [40],[43]. Glycerol is frequently used in BDS studies without justification, probably due to its low cost and availability, either supplementing a simple salt medium [11],[44] or in combination with complex nitrogen sources such as yeast extract [45]. Ethanol is less frequently used, although it has been shown to be the best among the examined carbon sources in fed-batch cultures of R. erythropolis KA-2-5-1 when it was simultaneously fed with DBT [43],[46] probably due to the additional reducing power (NADH) that provides during its catabolism, a fact that has also been predicted through flux-based analysis of sulfur metabolism in R. erythropolis [47]. In the present work, this seems to be also the case when ethanol is used for BDS catalyst production in combination with DMSO as the sole sulfur source. The inability of glucose to support the growth of all three R. qingshengii strains when supplied in a minimal salt medium with DMSO as sole sulfur source is a novel and rather unexpected result. Having in mind that in Gordonia alkanivorans [48] glucose can induce a lag-phase of more than 72 h, the glucose cultures were incubated for more than a week without achieving any substantial growth level, similarly to those depicted in Figure 3. A more scrutinous look on the relevant studies reveals that glucose had been used as carbon source in the past, but until recently, never in a minimal salt medium in combination with DMSO as the sole sulfur source [27]. Even in R. qingshengii IGTS8 studies where glucose (at 20 g/L) and DMSO are claimed to be the best combination of carbon and sulfur sources, respectively, with respect to growth and BDS activity, the basal medium employed contained an additional 20 g/L of glycerol [29],[40].

    In order to study the influence of sulfur source type, the growth of the microorganism using different types of water-soluble sulfur sources, namely, DMSO, DMSO2, taurine, and sulphate ions (as Na2SO4), has been carried out at an initial concentration of 1.3 mM, using ethanol as a carbon source (Figure 4). Τhere were no statistically significant differences in the growth pattern of each strain, with respect to the sulfur source used. As in the previous experimental set, R. qingshengii ATHUBA4003 and 4006 presented higher overall growth rates and almost 40% higher biomass yields compared to R. qingshengii IGTS8. Sulphate ions, although supported equivalent growth with the other S-sources, did not induce any significant BDS activity within the cells (data not shown). As far as the other three sulfur sources are concerned, DMSO was marginally the best inducer/non-repressor of BDS activity, with the positive effect being more profound at the beginning of the exponential and the stationary phases. Maximum BDS activity of the two new isolates, ATHUBA4003 and ATHUBA4006, was slightly higher than that of IGTS8 but the difference was statistically insignificant. When this result though, is combined with the higher biomass yield mentioned above, yields in an average 50% and 100% higher BDS volumetric productivity (Units/L culture volume) for ATHUBA4003 and ATHUBA 4006, respectively (supplementary data, Table S2).

    Only a few studies have systematically addressed the effect of various S-sources on BDS activity, while in most of them there is no clear justification on the choice of the S-source used. This work is focused on the examination of non dsz-operon-repressing, water-soluble, and low-cost sulfur sources, like DMSO, DMSO2, taurine and sulphate. As expected, SO4 ions at the applied concentration almost completely repressed the expression of the Dsz enzymes and the corresponding BDS activity. It is well-known that the BDS phenotype is repressed upon sulphate addition and relatively recently has been shown that this effect is probably due to the increase in the intracellular cysteine pool–which has an important role in the repression of the dsz-operon-caused by excess sulphate [42],[49]. DMSO has been often reported as the best sulfur source since it does not suppress the expression of the dsz-operon promoter [50]. Its use as the sole sulfur source to produce BDS biocatalysts is thus very often mentioned in literature and provides for enhanced specific BDS activity-even better than DBT–in addition to promoting better growth [40],[51]. Since DBT is immiscible with water, hence unsuitable for use in a practical commercial process, these results supported the notion that DMSO can be used as a water-soluble sulfur source for cultivation of Rhodococcus strains without causing an inhibitory effect on growth and hence higher desulfurization productivities can be achieved.

    Figure 4.  Effect of sulfur source type (at 1.3 mM), on growth (line-symbol plots) and specific desulfurization activities (bar plots) of (A), R. qingshengii IGTS8; (B), R. qingshengii ATHUBA4003; and (C), R. qingshengii ATHUBA4006 in CDM. Ethanol (165 mM) and NH4Cl at 0.8 g/L (15 mM) were used as carbon and nitrogen sources, respectively. “X” represents biomass concentration (mg/mL).

    Finally, the effect of nitrogen source type on growth and BDS activity of cells grown in cultures with ethanol and DMSO as carbon and sulfur sources, respectively, was examined (Figure 5, supplementary data Table S4). As in the two previous experimental sets, the two new R. qingshengii isolates performed significantly better than the model IGTS8 strain, both in terms of growth and specific BDS activity. One notable observation is that, in contrast to R. qingshengii ATHUBA4003 and 4006 isolates, R. qingshengii IGTS8 failed to grow in the medium with NaNO3 as the sole nitrogen source. An extensive literature search identified a limited number of studies not related to BDS, where Rhodococcus spp. were grown in only NO3 as nitrogen source [52],[53]; however, the growth of R. qingshengii IGTS8 on this nitrogen source has not been assessed previously. The recent genome announcement for IGTS8 identified certain nitrate-reducing enzymes and a nitrate/nitrite transporter (IGTS8_peg957, IGTS8_peg759, IGTS8_peg760, IGTS8_peg956, IGTS8_peg62) [10] and this is also the case for other Rhodococcus isolates [54]. The capability of the two new strains to grow on nitrate probably reflects their environmental origin, a hypothesis supported by the experimental results, specifically from the Keri marsh, in which nitrate levels in oil-impacted sites appeared to be enhanced compared to the non-oil-impacted ones [55]. This observation probably explains the more efficient uptake and/or catabolism of nitrate as the sole nitrogen source by R. qingshengii ATHUBA4003 and ATHUBA4006, although with significantly lower rates compared to the other sources.

    Figure 5.  Effect of nitrogen source type (at 15 mM-N), on growth (line-symbol plots) and specific desulfurization activities (bar plots) of (A) R. qingshengii IGTS8, (B) R. qingshengii ATHUBA4003, and (C) R. qingshengii ATHUBA4006 in CDM. Ethanol (165 mM) and DMSO (1.3 mM) were used as carbon and sulfur sources, respectively. “X” represents biomass concentration (mg/mL).

    As far as the other three nitrogen sources examined, ammonium chloride and urea supported higher BDS activities for all strains, although NH4Cl was significantly better in supporting microorganisms' growth. This goes in line with the majority of biodesulfurization studies where ammonium chloride is the preferred nitrogen source used for biocatalyst production [13],[40],[51]. It is widely known that most microbes preferentially utilize ammonium in order to avoid having to accomplish nitrate reduction-an energy-requiring process, but also, to avoid the inhibitory effects due to the decrease in the water activity and the extreme toxicity of nitrite and nitric oxide produced during the first steps of nitrate reduction to ammonium [56]. Finally, urea, a low-cost nitrogen source, has never been used before for BDS-biocatalyst production, but in the present work has been proven equally suited for enhanced specific BDS activity. It is quite interesting that for R. qingshengii ATHUBA 4003 and 4006, the maximum specific BDS activity with urea as nitrogen source, was observed at mid-log culture stages compared to the ammonium cultures where maximum BDS was achieved at the early log-phase. Combined with the lower growth kinetics in urea cultures, this observation probably reflects the time needed to reach the optimum expression levels of urease, known to be present in Rhodococcus genome [10].

    In addition to a high biodesulfurizing ability, a candidate biocatalyst should be able to withstand the harsh environment of an industrial-scale biphasic BDS system. To test the inherent stability of the new strains when in contact with petroleum products, we performed a series of lab-scale biphasic experiments using an HDS desulfurized diesel where both the viability of the added biocatalyst as well as its remaining BDS activity, at different oil-to-aqueous (O/A) phase ratios and different contact times were examined. The O/A phase ratios employed were 40%, 60% and 80% v/v, since lower ratios have no practical use in industrial BDS economics (Haruna et al. 2022; Acero, Berdugo, and Mogollón 2003). Two types of aqueous phases were additionally evaluated: In the first (Figure 6A), cells were washed and resuspended in HEPES buffer at the required concentration, while in the second (Figure 6B), whole broth at the same concentration was used directly as the aqueous phase (see Materials and Methods).

    Figure 6.  Residual BDS activity (upper panels) and cell viability (CFU count) (lower panels) of the microbial biomass in a biphasic system with diesel fuel. Cells were removed from cultures, at the optimum conditions (ethanol, DMSO, NH4Cl), washed twice with Ringer's solution (A) or used directly (B) in the biphasic system, at a concentration of 0.5 ± 0.05 mgDCW/mL in the aqueous phase. For all three strains, the initial (t = 0 h) BDS activity was between 19.4 and 24.2 U/mg DCW and the initial CFU count between 6.9 and 8.7 x 108 CFU/mL.

    The contact of the aqueous phase with the HDS diesel in a biphasic biodesulfurization environment has resulted in significant losses of the BDS activity especially for the washed biocatalyst cells (Figure 6A-left diagrams). In the case of R. qingshengii IGTS8 the activity loss is very significant reaching 85 and 96% after 4 and 24 h incubation at the 40/60 oil-to-aqueous (O/A) ratio. At higher O/A ratios the losses were even greater. The stability profile for the two new R. qingshengii strains were significantly better though, especially at the 4 h incubation time, probably due to the prolonged exposure to crude oil in their natural habitat that transfused them with the necessary genetic traits to withstand diesel toxicity. It cannot be conferred at this stage though, whether this decreased rate of activity loss for the two new R. qingshengii strains, is a result of more stable 4S enzyme structures or a consequence of their evolutionary history that provides them with membranes less permeable to the toxic or enzyme inhibiting compounds of diesel.

    Another very important observation is the fact that in general, the determined BDS activity losses are not directly related to the corresponding viability losses. This observation reflects the fact that during a biphasic BDS system, the 4S-pathway enzymes lose their functionality at a much greater rate compared to cells' survival mechanism. The two new strains though, lost on average only a small fraction of their viability (between 10 to 25%) upon 4 h contact with the diesel even at the high O/A ratio. In fact, high viabilities (over 50%) were maintained after 24 h incubation in the biphasic system for the two lower O/A ratios. The same pattern was also observed even for R. qingshengii IGTS8, but to a much lesser extent and basically only for the low O/A ratio of 40/60.

    No studies where the biocatalyst's viability in a biphasic system with pragmatic (oil product) organic phases is correlated with the corresponding BDS activities were found, since such systems are usually studied through the kinetics of sulfur-content reduction as a function of various process parameters such as the O/A ratio, the biomass concentration in the aqueous phase etc. [57]. On the other hand, the most detailed studies on the quantitative aspects of a biphasic BDS system are performed using only “model-oils” where DBT and its derivatives are diluted in pure C12–C16 matrices [58],[59]. In a similar to the present work situation, but in a model-C16 system and 50/50 O/A ratio, R. globerulus resting cells lost almost completely their BDS activity after 24 h incubation while they maintained about 90% of their initial viability [60]. Finally in another very interesting study, with Rhodococcus sp. SA11 cells growing in a basal DBT-glycerol medium with the addition of different crude oil volumes up to a 50/50 ratio, the cells' viability was drastically decreased in the first 48 h compared to the culture with no oil addition [13]. In the same experiment, this viability difference was alleviated at higher growth times, but unfortunately no BDS activities were measured in parallel. The general trend though in this and other relevant studies is that when oil and oil-products O/A ratio is increased, a gradual reduction of the BDS conversion rates is observed, a fact that is also the case in the present work.

    A second, equally important result with respect to the process economics was revealed when the use of the biocatalyst directly from the fermentation broth without any other treatment was examined, at equivalent conditions and concentrations in the biphasic systems (Figure 6B). A significant increase in both residual BDS activity and CFU count was observed for all three Rhodococcus strains especially at the 4h incubation time, in comparison with the corresponding use of washed biocatalyst. For the IGTS8 strain in particular, this increase was quite significant. Again, the two new isolates ATHUBA 4003 and 4006 revealed a better stability profile, retaining almost 50% of their initial BDS activity after 4 h in the 40/60 and 60/40 O/A ratios. These two isolates did not show any viability losses and, apparently, achieved some growth in the aqueous phases of all biphasic systems. The fact that this trend is observed for all three studied strains probably reflects either a protective effect of the spent growth medium on the intracellular physiology the Dsz-enzymes' activities or an opposite effect of the washing process (or a combination of both these factors).

    In all referred resting-cells' biphasic studies with crude oil or oil derivatives as organic phase, the aqueous phase is comprised of cells grown in a Dsz-enzymes' inducing medium, collected at the time of maximum BDS activity, washed with a suitable buffer, and finally added in the biphasic system [13],[61]. It is easy to envisage that this final washing step is time- and cost-consuming when translated into a real-life industrial BDS system that requires large amounts of active biocatalyst. The fact that whole-broth-cells of the two new R. qingshengii isolates (and IGTS8) have revealed enhanced stability with respect to their BDS activity, compared to the washed cells in real-life biphasic biodesulfurization systems, is an overlooked characteristic of the overall biodesulfurization process cascade with obvious positive effect on process economics.

    The targeted search of new biodesulfurization strains from environments of prolonged oil presence, can result in the isolation of microbial strains with improved BDS phenotypes. This was proven for the Keri marsh, the habitat from where two new R. qingshengii ATHUBA 4003 and ATHUBA 4006 were isolated. These strains have revealed elevated desulfurizing capabilities that where combined with enhanced stability properties as unveiled from a unique and diesel-oriented experimental approach that has been followed. Thus, they correspond to highly promising starting points for additional genetic and process optimization studies that could eventually lead to an economically viable industrial BDS process.



    Conflict of interest



    The authors declare no conflict of interest.

    [1] Shi H, Xia Y, Gu R, et al. (2021) Ginseng adjuvant therapy on COVID-19: A protocol for systematic review and meta-analysis. Medicine 100: e27586. https://doi.org/10.1097/MD.0000000000027586
    [2] Ghibu S, Juncan AM, Rus LL, et al. (2021) The particularities of pharmaceutical care in improving public health service during the COVID-19 pandemic. Int J Environ Res Public Health 18: 9776. https://doi.org/10.3390/ijerph18189776
    [3] Paudyal V, Sun S, Hussain R, et al. (2022) Complementary and alternative medicines use in COVID-19: A global perspective on practice, policy and research. Res Soc Admin Pharm 18: 2524-2528. https://doi.org/10.1016/j.sapharm.2021.05.004
    [4] Wee JJ (2011) Biological activities of ginseng and its application to human health. Herbal Medicine: Biomolecular and Clinical Aspects . Boca Raton: CRC Press/Taylor & Francis.
    [5] Wu H, Høiby N, Yang L, et al. (2014) Effects of radix ginseng on microbial infections: a narrative review. J Tradit Chin Med 34: 227-233. https://doi.org/10.1016/s0254-6272(14)60083-2
    [6] Shishtar E, Sievenpiper JL, Djedovic V, et al. (2014) The effect of ginseng (the genus panax) on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials. PloS One 9: e107391. https://doi.org/10.1371/journal.pone.0107391
    [7] Lee CS, Lee JH, Oh M, et al. (2012) Preventive effect of Korean red ginseng for acute respiratory illness: a randomized and double-blind clinical trial. J Korean Med Sci 27: 1472-1478. https://doi.org/10.3346/jkms.2012.27.12.1472
    [8] Mancuso C, Santangelo R (2017) Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem Toxicol 1107: 362-372. https://doi.org/10.1016/j.fct.2017.07.019
    [9] Karmazyn M, Gan XT (2021) Chemical components of ginseng, their biotransformation products and their potential as treatment of hypertension. Mol Cell Biochem 476: 333-347. https://doi.org/10.1007/s11010-020-03910-8
    [10] Choi KT (2008) Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng CA Meyer. Acta Pharmacol Sin 29: 1109-1118. https://doi.org/10.1111/j.1745-7254.2008.00869.x
    [11] Yang Y, Ren C, Zhang Y, et al. (2017) Ginseng: An nonnegligible natural remedy for healthy aging. Aging Dis 8: 708-720. https://doi.org/10.14336/AD.2017.0707
    [12] You L, Cha S, Kim MY, et al. (2022) Ginsenosides are active ingredients in Panax ginseng with immunomodulatory properties from cellular to organismal levels. J Ginseng Res 46: 711-721. https://doi.org/10.1016/j.jgr.2021.12.007
    [13] Qi LW, Wang CZ, Du GJ, et al. (2011) Metabolism of ginseng and its interactions with drugs. Curr Drug Metab 12: 818-822. https://doi.org/10.2174/138920011797470128
    [14] Zhang H, Abid S, Ahn JC, et al. (2020) Characteristics of Panax ginseng cultivars in Korea and China. Molecules 25: 2635. https://doi.org/10.3390/molecules25112635
    [15] Kitts D, Hu C (2000) Efficacy and safety of ginseng. Public Health Nutr 3: 473-485. https://doi.org/10.1017/S1368980000000550
    [16] Zhang Y, Zheng Y, Xia P, et al. (2019) Impact of continuous Panax notoginseng plantation on soil microbial and biochemical properties. Sci Rep 9: 13205. https://doi.org/10.1038/s41598-019-49625-9
    [17] Hyun SH, Kim SW, Seo HW, et al. (2020) Physiological and pharmacological features of the non-saponin components in Korean Red Ginseng. J Ginseng Res 44: 527-537. https://doi.org/10.1016/j.jgr.2020.01.005
    [18] Ratan ZA, Haidere MF, Hong YH, et al. (2021) Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res 45: 199-210. https://doi.org/10.1016/j.jgr.2020.02.004
    [19] Yin X, Hu H, Shen X, et al. (2021) Ginseng omics for ginsenoside biosynthesis. Curr Pharm Biotechnol 22: 570-578. https://doi.org/10.2174/1389201021666200807113723
    [20] Razgonova MP, Veselov VV, Zakharenko AM, et al. (2019) Panax ginseng components and the pathogenesis of Alzheimer's disease. Mol Med Rep 19: 2975-2998. https://doi.org/10.3892/mmr.2019.9972
    [21] Yao W, Guan Y (2022) Ginsenosides in cancer: A focus on the regulation of cell metabolism. Biomed Pharmacother 156: 113756. https://doi.org/10.1016/j.biopha.2022.113756
    [22] Qi HY, Li L, Ma H (2018) Cellular stress response mechanisms as therapeutic targets of ginsenosides. Med Res Rev 38: 625-654. https://doi.org/10.1002/med.21450
    [23] Kim H, Lee JH, Kim JE, et al. (2018) Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability. J Ginseng Res 42: 361-369. https://doi.org/10.1016/j.jgr.2017.12.003
    [24] Lee JO, Kim JH, Kim S, et al. (2020) Gastroprotective effects of the nonsaponin fraction of Korean Red Ginseng through cyclooxygenase-1 upregulation. J Ginseng Res 44: 655-663. https://doi.org/10.1016/j.jgr.2019.11.001
    [25] Ratan ZA, Youn SH, Kwak YS, et al. (2021) Adaptogenic effects of Panax ginseng on modulation of immune functions. J Ginseng Res 45: 32-40. https://doi.org/10.1016/j.jgr.2020.09.004
    [26] Choi MK, Song IS (2019) Interactions of ginseng with therapeutic drugs. Arch Pharm Res 42: 862-878. https://doi.org/10.1007/s12272-019-01184-3
    [27] Kim JH, Kim DH, Jo S, et al. (2022) Immunomodulatory functional foods and their molecular mechanisms. Exp Mol Med 54: 1-11. https://doi.org/10.1038/s12276-022-00724-0
    [28] Taguchi T, Mukai K (2019) Innate immunity signalling and membrane trafficking. Curr Opin Cell Biol 59: 1-7. https://doi.org/10.1016/j.ceb.2019.02.002
    [29] Youn SH, Lee SM, Han CK, et al. (2020) Immune activity of polysaccharide fractions isolated from Korean Red Ginseng. Molecules 25: 3569. https://doi.org/10.3390/molecules25163569
    [30] He LX, Ren JW, Liu R, et al. (2017) Ginseng (Panax ginseng Meyer) oligopeptides regulate innate and adaptive immune responses in mice via increased macrophage phagocytosis capacity, NK cell activity and Th cells secretion. Food Funct 8: 3523-3532. https://doi.org/10.1039/C7FO00957G
    [31] Shin JY, Song JY, Yun YS, et al. (2002) Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol Immunotoxicol 24: 469-482. https://doi.org/10.1081/IPH-120014730
    [32] Han MJ, Kim DH (2020) Effects of red and fermented ginseng and ginsenosides on allergic disorders. Biomolecules 10: 634. https://doi.org/10.3390/biom10040634
    [33] Gu Z, Ling J, Cong J, et al. (2020) A review of therapeutic effects and the pharmacological molecular mechanisms of Chinese medicine weifuchun in treating precancerous gastric conditions. Integr Cancer Ther 19: 1534735420953215. https://doi.org/10.1177/1534735420953215
    [34] Lee DY, Park CW, Lee SJ, et al. (2019) Immunostimulating and antimetastatic effects of polysaccharides purified from ginseng berry. Am J Chin Med 47: 823-839. https://doi.org/10.1142/S0192415X19500435
    [35] Zhang X, Liu Z, Zhong C, et al. (2021) Structure characteristics and immunomodulatory activities of a polysaccharide RGRP-1b from radix ginseng Rubra. Int J Biol Macromol 189: 980-992. https://doi.org/10.1016/j.ijbiomac.2021.08.176
    [36] Lim DS, Bae KG, Jung IS, et al. (2002) Anti-septicaemic effect of polysaccharide from Panax ginseng by macrophage activation. J Infect 45: 32-38. https://doi.org/10.1053/jinf.2002.1007
    [37] Gao H, Kang N, Hu C, et al. (2020) Ginsenoside Rb1 exerts anti-inflammatory effects in vitro and in vivo by modulating toll-like receptor 4 dimerization and NF-kB/MAPKs signaling pathways. Phytomedicine 69: 153197. https://doi.org/10.1016/j.phymed.2020.153197
    [38] Zhou P, Lu S, Luo Y, et al. (2017) Attenuation of TNF-a-induced inflammatory injury in endothelial cells by ginsenoside Rb1 via inhibiting NF-kB, JNK and p38 signaling pathways. Front Pharmacol 8: 464. https://doi.org/10.3389/fphar.2017.00464
    [39] Chen S, Li X, Wang Y, et al. (2019) Ginsenoside Rb1 attenuates intestinal ischemia/reperfusion‑induced inflammation and oxidative stress via activation of the PI3K/Akt/Nrf2 signaling pathway. Mol Med Rep 19: 3633-3641. https://doi.org/10.3892/mmr.2019.10018
    [40] Byun J, Kim SK, Ban JY (2021) Anti-Inflammatory and anti-oxidant effects of Korean Ginseng berry extract in LPS-activated RAW264.7 macrophages. Am J Chin Med 49: 719-735. https://doi.org/10.1142/S0192415X21500336
    [41] Yao F, Xue Q, Li K, et al. (2019) Phenolic compounds and ginsenosides in ginseng shoots and their antioxidant and anti-inflammatory capacities in LPS-induced RAW264.7 mouse macrophages. Int J Mol Sci 20: 2951. https://doi.org/10.3390/ijms20122951
    [42] Prager I, Watzl C (2019) Mechanisms of natural killer cell-mediated cellular cytotoxicity. J Leukoc Biol 105: 1319-1329. https://doi.org/10.1002/JLB.MR0718-269R
    [43] Kwon HJ, Lee H, Choi GE, et al. (2018) Ginsenoside F1 promotes cytotoxic activity of NK cells via insulin-like growth factor-1-dependent mechanism. Front Immunol 9: 2785. https://doi.org/10.3389/fimmu.2018.02785
    [44] Sun Y, Guo M, Feng Y, et al. (2016) Effect of ginseng polysaccharides on NK cell cytotoxicity in immunosuppressed mice. Exp Ther Med 12: 3773-3777. https://doi.org/10.3892/etm.2016.3840
    [45] Wang Z, Meng J, Xia Y, et al. (2013) Maturation of murine bone marrow dendritic cells induced by acidic Ginseng polysaccharides. Int J Biol Macromol 53: 93-100. https://doi.org/10.1016/j.ijbiomac.2012.11.009
    [46] Zhang W, Cho SY, Xiang G, et al. (2015) Ginseng berry extract promotes maturation of mouse dendritic cells. PloS One 10: e0130926. https://doi.org/10.1371/journal.pone.0130926
    [47] Takei M, Tachikawa E, Umeyama A (2008) Dendritic cells promoted by ginseng saponins drive a potent Th1 polarization. Biomark Insights 3: 269-286. https://doi.org/10.4137/BMI.S585
    [48] Larsen MW, Moser C, Hoiby N, et al. (2004) Ginseng modulates the immune response by induction of interleukin-12 production. APMIS 112: 369-373. https://doi.org/10.1111/j.1600-0463.2004.apm1120607.x
    [49] Lee EJ, Ko E, Lee J, et al. (2004) Ginsenoside Rg1 enhances CD4(+) T-cell activities and modulates Th1/Th2 differentiation. Int Immunopharmacol 4: 235-244. https://doi.org/10.1016/j.intimp.2003.12.007
    [50] Berek L, Szabó D, Petri IB, et al. (2001) Effects of naturally occurring glucosides, solasodine glucosides, ginsenosides and parishin derivatives on multidrug resistance of lymphoma cells and leukocyte functions. In Vivo 15: 151-156.
    [51] Cho M, Choi G, Shim I, et al. (2019) Enhanced Rg3 negatively regulates Th1 cell responses. J Ginseng Res 43: 49-57. https://doi.org/10.1016/j.jgr.2017.08.003
    [52] Rivera E, Pettersson FE, Inganäs M, et al. (2005) The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response. Vaccine 23: 5411-5419. https://doi.org/10.1016/j.vaccine.2005.04.007
    [53] Zhang L, Feng H, He Y, et al. (2017) Ginseng saponin Rb1 enhances hematopoietic function and dendritic cells differentiation. Acta Biochim Biophys Sin 49: 746-749. https://doi.org/10.1093/abbs/gmx062
    [54] Park HY, Lee SH, Lee KS, et al. (2015) Ginsenoside Rg1 and 20(S)-Rg3 induce IgA production by mouse B cells. Immune Netw 15: 331-336. https://doi.org/10.4110/in.2015.15.6.331
    [55] Rabaan AA, Al-Ahmed SH, Haque S, et al. (2020) SARS-CoV-2, SARS-CoV, and MERS-CoV: A comparative overview. Infez Med 28: 174-184.
    [56] Lu R, Zhao X, Li J, et al. (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395: 565-574. https://doi.org/10.1016/S0140-6736(20)30251-8
    [57] Giovanetti M, Benedetti F, Campisi G, et al. (2021) Evolution patterns of SARS-CoV-2: Snapshot on its genome variants. Biochem Biophys Res Commun 538: 88-91. https://doi.org/10.1016/j.bbrc.2020.10.102
    [58] Wu A, Peng Y, Huang B, et al. (2020) Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe 27: 325-328. https://doi.org/10.1016/j.chom.2020.02.001
    [59] Fontanet A, Autran B, Lina B, et al. (2021) SARS-CoV-2 variants and ending the COVID-19 pandemic. Lancet 397: 952-954. https://doi.org/10.1016/S0140-6736(21)00370-6
    [60] Aleem A, Samad ABA, Vaqar S (2023) Emerging variants of SARS-CoV-2 and novel therapeutics against coronavirus (COVID-19). StatPearls . Treasure Island: StatPearls Publishing.
    [61] Schultze JL, Aschenbrenner AC (2021) COVID-19 and the human innate immune system. Cell 184: 1671-1692. https://doi.org/10.1016/j.cell.2021.02.029
    [62] Vabret N, Britton GJ, Gruber C, et al. (2020) Immunology of COVID-19: Current state of the science. Immunity 52: 910-941. https://doi.org/10.1016/j.immuni.2020.05.002
    [63] Sette A, Crotty S (2021) Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184: 861-880. https://doi.org/10.1016/j.cell.2021.01.007
    [64] Jordan SC (2021) Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses. Clin Exp Immunol 204: 310-320. https://doi.org/10.1111/cei.13582
    [65] Cohen SA, Kellogg C, Equils O (2021) Neutralizing and cross-reacting antibodies: implications for immunotherapy and SARS-CoV-2 vaccine development. Hum Vaccin Immunother 17: 84-87. https://doi.org/10.1080/21645515.2020.1787074
    [66] Winheim E, Rinke L, Lutz K, et al. (2021) Impaired function and delayed regeneration of dendritic cells in COVID-19. PloS Pathog 17: e1009742. https://doi.org/10.1371/journal.ppat.1009742
    [67] Carsetti R, Zaffina S, Mortari EP, et al. (2020) Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases. Front Immunol 11: 610300. https://doi.org/10.3389/fimmu.2020.610300
    [68] Liao M, Liu Y, Yuan J, et al. (2020) Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med 26: 842-844. https://doi.org/10.1038/s41591-020-0901-9
    [69] Paces J, Strizova Z, Smrz D, et al. (2020) COVID-19 and the immune system. Physiol Res 69: 379-388. https://doi.org/10.33549/physiolres.934492
    [70] de Candia P, Prattichizzo F, Garavelli S, et al. (2021) T cells: Warriors of SARS-CoV-2 infection. Trends Immunol 42: 18-30. https://doi.org/10.1016/j.it.2020.11.002
    [71] Fernandes Q, Inchakalody VP, Merhi M, et al. (2022) Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann Med 54: 524-540. https://doi.org/10.1080/07853890.2022.2031274
    [72] Hwang YC, Lu RM, Su SC, et al. (2022) Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection. J Biomed Sci 29: 1. https://doi.org/10.1186/s12929-021-00784-w
    [73] Nguyen NH, Nguyen CT (2019) Pharmacological effects of ginseng on infectious diseases. Inflammopharmacology 27: 871-883. https://doi.org/10.1007/s10787-019-00630-4
    [74] Alsayari A, Muhsinah AB, Almaghaslah D, et al. (2021) Pharmacological efficacy of ginseng against respiratory tract infections. Molecules 26: 4095. https://doi.org/10.3390/molecules26134095
    [75] Dong W, Farooqui A, Leon AJ, et al. (2017) Inhibition of influenza A virus infection by ginsenosides. PloS One 12: e0171936. https://doi.org/10.1371/journal.pone.0171936
    [76] Lee JS, Lee YN, Lee YT, et al. (2015) Ginseng protects against respiratory syncytial virus by modulating multiple immune cells and inhibiting viral replication. Nutrients 7: 1021-1036. https://doi.org/10.3390/nu7021021
    [77] Lee JS, Cho MK, Hwang HS, et al. (2014) Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses. J Interferon Cytokine Res 34: 902-914. https://doi.org/10.1089/jir.2013.0093
    [78] Yoo DG, Kim MC, Park MK, et al. (2012) Protective effect of Korean red ginseng extract on the infections by H1N1 and H3N2 influenza viruses in mice. J Med Food 15: 855-862. https://doi.org/10.1089/jmf.2012.0017
    [79] Lee WS, Rhee DK (2021) Corona-Cov-2 (COVID-19) and ginseng: Comparison of possible use in COVID-19 and influenza. J Ginseng Res 45: 535-537. https://doi.org/10.1016/j.jgr.2020.12.005
    [80] Boopathi V, Nahar J, Murugesan M, et al. (2023) In silico and in vitro inhibition of host-based viral entry targets and cytokine storm in COVID-19 by ginsenoside compound K. Heliyon 9: e19341. https://doi.org/10.1016/j.heliyon.2023.e19341
    [81] Seo SH (2022) Ginseng protects ACE2-transgenic mice from SARS-CoV-2 infection. Front Biosci 27: 180. https://doi.org/10.31083/j.fbl2706180
    [82] Cho IH (2012) Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res 36: 342-353. https://doi.org/10.5142/jgr.2012.36.4.342
    [83] de Oliveira Zanuso B, Dos Santos ARO, Miola VFB, et al. (2022) Panax ginseng and aging related disorders: A systematic review. Exp Gerontol 161: 111731. https://doi.org/10.1016/j.exger.2022.111731
    [84] Szczuka D, Nowak A, Zakłos-Szyda M, et al. (2019) American Ginseng (Panax quinquefolium L.) as a source of bioactive phytochemicals with pro-health properties. Nutrients 11: 1041. https://doi.org/10.3390/nu11051041
    [85] Kaiser R, Leunig A, Pekayvaz K, et al. (2021) Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight 6: e150862. https://doi.org/10.1172/jci.insight.150862
    [86] Liu T, Zhang J, Yang Y, et al. (2019) The role of interleukin-6 in monitoring severe case of coronavirus disease 2019. EMBO Mol Med 12: e12421. https://doi.org/10.15252/emmm.202012421
    [87] Laforge M, Elbim C, Frère C, et al. (2020) Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol 20: 515-516. https://doi.org/10.1038/s41577-020-0407-1
    [88] Saba E, Jeong D, Irfan M, et al. (2018) Anti-inflammatory activity of Rg3-enriched Korean Red Ginseng extract in murine model of sepsis. Evid Based Complement Alternat Med 2018: 6874692. https://doi.org/10.1155/2018/6874692
    [89] Huang WC, Huang TH, Yeh KW, et al. (2021) Ginsenoside Rg3 ameliorates allergic airway inflammation and oxidative stress in mice. J Ginseng Res 45: 654-664. https://doi.org/10.1016/j.jgr.2021.03.002
    [90] Tu C, Wan B, Zeng Y (2020) Ginsenoside Rg3 alleviates inflammation in a rat model of myocardial infarction via the SIRT1/NF-κB pathway. Exp Ther Med 20: 238. https://doi.org/10.3892/etm.2020.9368
    [91] Yang S, Li F, Lu S, et al. (2022) Ginseng root extract attenuates inflammation by inhibiting the MAPK/NF-κB signaling pathway and activating autophagy and p62-Nrf2-Keap1 signaling in vitro and in vivo. J Ethnopharmacol 283: 114739. https://doi.org/10.1016/j.jep.2021.114739
    [92] Yi YS (2022) Potential benefits of ginseng against COVID-19 by targeting inflammasomes. J Ginseng Res 46: 722-730. https://doi.org/10.1016/j.jgr.2022.03.008
    [93] Jung EM, Lee GS (2022) Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic. J Ginseng Res 46: 331-336. https://doi.org/10.1016/j.jgr.2022.02.003
    [94] Han BC, Ahn H, Lee J, et al. (2017) Nonsaponin fractions of Korean Red Ginseng extracts prime activation of NLRP3 inflammasome. J Ginseng Res 41: 513-523. https://doi.org/10.1016/j.jgr.2016.10.001
    [95] Feng J, Fang B, Zhou D, et al. (2021) Clinical effect of traditional Chinese medicine Shenhuang granule in critically ill patients with COVID-19: A single-centered, retrospective, observational study. J Microbiol Biotechnol 31: 380-386. https://doi.org/10.4014/jmb.2009.09029
    [96] Kang S, Min H (2012) Ginseng, the “Immunity Boost”: The effects of Panax ginseng on immune system. J Ginseng Res 36: 354-368. https://doi.org/10.5142/jgr.2012.36.4.354
    [97] Qu DF, Yu HJ, Liu Z, et al. (2011) Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen. Vet Parasitol 179: 28-34. https://doi.org/10.1016/j.vetpar.2011.02.008
    [98] Xu ML, Kim HJ, Choi YR, et al. (2012) Intake of korean red ginseng extract and saponin enhances the protection conferred by vaccination with inactivated influenza a virus. J Ginseng Res 36: 396-402. https://doi.org/10.5142/jgr.2012.36.4.396
    [99] Rhee DK (2022) COVID-19 infection and ginseng: Predictive influenza virus strains and non-predictive COVID-19 vaccine strains. J Ginseng Res 47: 347-348. https://doi.org/10.1016/j.jgr.2022.12.007
    [100] Kim JH (2012) Cardiovascular diseases and Panax ginseng: A review on molecular mechanisms and medical applications. J Ginseng Res 36: 16-26. https://doi.org/10.5142/jgr.2012.36.1.16
    [101] Hossain MA, Kim JH (2022) Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review. J Ginseng Res 46: 321-330. https://doi.org/10.1016/j.jgr.2022.01.003
    [102] Lee YY, Quah Y, Shin JH, et al. (2022) COVID-19 and Panax ginseng: Targeting platelet aggregation, thrombosis and the coagulation pathway. J Ginseng Res 46: 175-182. https://doi.org/10.1016/j.jgr.2022.01.002
    [103] Quah Y, Lee YY, Lee SJ, et al. (2022) In silico investigation of Panax ginseng lead compounds against COVID-19 associated platelet activation and thromboembolism. J Ginseng Res 47: 283-290. https://doi.org/10.1016/j.jgr.2022.09.001
    [104] Irfan M, Jeong D, Kwon HW, et al. (2018) Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling. Vasc Pharmacol 109: 45-55. https://doi.org/10.1016/j.vph.2018.06.002
    [105] Jeong D, Irfan M, Kim SD, et al. (2017) Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation. J Ginseng Res 41: 548-555. https://doi.org/10.1016/j.jgr.2016.11.003
    [106] Yi XQ, Li T, Wang JR, et al. (2010) Total ginsenosides increase coronary perfusion flow in isolated rat hearts through activation of PI3K/Akt-eNOS signaling. Phytomedicine 17: 1006-1015. https://doi.org/10.1016/j.phymed.2010.06.012
    [107] Irfan M, Lee YY, Lee KJ, et al. (2021) Comparative antiplatelet and antithrombotic effects of red ginseng and fermented red ginseng extracts. J Ginseng Res 46: 387-395. https://doi.org/10.1016/j.jgr.2021.05.010
    [108] Kang SY, Kim SH, Schini VB, et al. (1995) Dietary ginsenosides improve endothelium dependent relaxation in the thoracic aorta of hypercholesterolemic rabbit. Gen Pharmacol 26: 483-487. https://doi.org/10.1016/0306-3623(95)94002-X
    [109] Wang Z, Li YF, Han XY, et al. (2018) Kidney protection effect of ginsenoside re and its underlying mechanisms on cisplatin-induced kidney injury. Cell Physiol Biochem 48: 2219-2229. https://doi.org/10.1159/000492562
    [110] Karunasagara S, Hong GL, Park SR, et al. (2020) Korean red ginseng attenuates hyperglycemia-induced renal inflammation and fibrosis via accelerated autophagy and protects against diabetic kidney disease. J Ethnopharmacol 254: 112693. https://doi.org/10.1016/j.jep.2020.112693
    [111] Mariage PA, Hovhannisyan A, Panossian AG (2020) Efficacy of panax ginseng meyer herbal preparation HRG80 in preventing and mitigating stress-induced failure of cognitive functions in healthy subjects: A pilot, randomized, double-blind, placebo-controlled crossover trial. Pharmaceuticals 13: 57. https://doi.org/10.3390/ph13040057
    [112] Teitelbaum J, Goudie S (2021) An open-label, pilot trial of HRG80™ red ginseng in chronic fatigue syndrome, fibromyalgia, and post-viral fatigue. Pharmaceuticals 15: 43. https://doi.org/10.3390/ph15010043
    [113] Yuan HD, Kim JT, Kim SH, et al. (2012) Ginseng and diabetes: the evidences from in vitro, animal and human studies. J Ginseng Res 36: 27-39. https://doi.org/10.5142/jgr.2012.36.1.27
    [114] Yang L, Zou H, Gao Y, et al. (2020) Insights into gastrointestinal microbiota-generated ginsenoside metabolites and their bioactivities. Drug Metab Rev 52: 125-138. https://doi.org/10.1080/03602532.2020.1714645
    [115] Lee JI, Park KS, Cho IH (2019) Panax ginseng: a candidate herbal medicine for autoimmune disease. J Ginseng Res 43: 342-348. https://doi.org/10.1016/j.jgr.2018.10.002
    [116] Zhang M, Ren H, Li K, et al. (2021) Therapeutic effect of various ginsenosides on rheumatoid arthritis. BMC Complement Med Ther 21: 149. https://doi.org/10.1186/s12906-021-03302-5
    [117] Iqbal H, Rhee DK (2020) Ginseng alleviates microbial infections of the respiratory tract: a review. J Ginseng Res 44: 194-204. https://doi.org/10.1016/j.jgr.2019.12.001
    [118] Wang L, Huang Y, Yin G, et al. (2020) Antimicrobial activities of Asian ginseng, American ginseng, and notoginseng. Phytother Res 34: 1226-1236. https://doi.org/10.1002/ptr.6605
    [119] WHO, WHO Director-General's opening remarks at the media briefing on COVID-19. World Health Organization (2020) . Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
    [120] WHO, COVID-19 Epidemiological Update - 29 September 2023. World Health Organization (2023) . Available from: https://www.who.int/publications/m/item/covid-19-epidemiological-update---29-september-2023
    [121] Vitiello A, Ferrara F, Troiano V, et al. (2021) COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology 29: 1357-1360. https://doi.org/10.1007/s10787-021-00847-2
    [122] Nisar B, Sultan A, Rbab SL (2017) Comparison of medicinally important natural products versus synthetic drugs—A short commentary. Nat Prod Chem Res 6: 308. https://doi.org/10.4172/2329-6836.1000308
    [123] Lin L, Hsu W, Lin C (2014) Antiviral natural products and herbal medicines. J Tradit Complement Med 4: 24-35. https://doi.org/10.4103/2225-4110.124335
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2590) PDF downloads(87) Cited by(1)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog